China Healthcare

China Healthcare
  • Pininvest Analysis

No one doubts health care in China is becoming an ever bigger story and no one will be surprised to see the Chinese authorities focus doggedly on strengthening the country’s pharmaceutical expertise

With most of the pharmaceutical businesses quoted on Chinese stock markets, American investors may be advised to refer to our theme of US listed companies as informative – but partial – guidelines regarding some of the Chinese health care trends

  • Not all the OTC-listed companies appear to be actively traded, though successfully introduced on the Chinese market
  • High valuations may in many cases reflect a tendency of the Chinese investors to ‘overshoot’ in a spurt of optimism

The overall growth perspectives, and the will to ensure Chinese companies are the immediate beneficiaries, are unquestionable – foreign providers, such as Novo Nordisk of Denmark NVO/NYSE in the diabetes market, are well aware of the challenge

Read our note

China Healthcare • Updated:

Name Ticker Exchange Sector Industry Currency Cur.Price Mkt.Cap Perf. Vol. Risk Contrib. MDD
 
BeiGene, Ltd BGNE NASDAQ Health Care Gene Editing - Cell Therapies USD 132.01 8.0 B -17.5% 52%   7% -39%
Cellular Biomedicine CBMG NASDAQ Health Care Biopharmaceuticals USD 14.84 286 M -24.9% 70%   7% -53%
Concord Medical Services CCM NYSE Health Care Healthcare Facilities & Services USD 2.30 100 M -34.3% 68%   4% -52%
CSPC Pharmaceutical Group CHJTF OTC Health Care Drug Manufacturers - Diversified USD 1.62 - -36.9% 49%   3% -47%
Guangzhou Baiyunshan Pharmaceutical Holdings GZPHF OTC Health Care Drug Manufacturers - Diversified USD 3.65 - 0.6% 21%   1% -17%
Hutchison China MediTech HCM NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 20.46 2.7 B -28.0% 61%   7% -48%
Novo Nordisk NVO NYSE Health Care Diabetes USD 49.48 121 B 6.0% 22%   2% -14%
Shandong Weigao Group Medical SHWGY OTC Health Care Medical Consumables & Intermediates USD 4.41 - 61.1% 48%   9% -21%
Shanghai Fosun Pharmaceutical SFOSF OTC Health Care Drug Manufacturers - Diversified USD 2.98 - -17.8% 40%   5% -32%
Shanghai Pharmaceuticals SHPMY OTC Health Care Drug Manufacturers - Diversified USD 9.72 - -21.3% 26%   1% -34%
Sihuan Pharmaceutical Holdings SHPHF OTC Health Care Drug Manufacturers - Diversified USD 0.20 - -6.1% 55%   2% -35%
Sino Biopharmaceutical SBMFF OTC Health Care Drug Manufacturers - Diversified USD 1.42 - 58.9% 57%   20% -46%
Sinopharm Group SHTDF OTC Health Care Drug Manufacturers - Diversified USD 3.35 - -28.3% 30%   2% -31%
Tong Ren Tang Technologies TGRNF OTC Health Care Drug Manufacturers - Diversified USD 1.22 - -15.9% 17%   0% -19%
WuXi Biologics (Cayman) WXXWY OTC Health Care Medical Laboratories & Research USD 20.34 - 12.0% 52%   11% -42%
Zai Lab ZLAB NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 34.25 2.0 B 84.2% 49%   19% -21%